Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ultragenyx Pharmaceuticals reviews pipeline

Jan. 19, 2015

Safety and dosing data presented for a novel gastric cancer vaccine

Jan. 19, 2015

Acorda Therapeutics provides overview on ongoing projects

Jan. 19, 2015

Phase I results presented for AMG-377 treatment of gastrointestinal tumors

Jan. 16, 2015

Alexion describes pipeline outlook at JP Morgan Healthcare Conference

Jan. 16, 2015

Promising results presented for chimeric antigen receptors in B-cell cancer treatment

Jan. 15, 2015

Novel biomarker associated with MDD

Jan. 14, 2015

Bench-side progress towards novel therapies for myeloid tumors

Jan. 14, 2015

New vasopressin V1A receptor antagonist found to influence social cognition

Jan. 14, 2015

GlyT1 inhibitor improves cognition and sociability in mouse model of ASD

Jan. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
Quince’s eDSP on ice after Neat phase III fails in A-T
BioWorld
Quince Therapeutics Inc. is scrapping work with dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP) for patients with...